Harvard Early Detection and Interception of Cancer Current Practice Recommendations and Novel Emerging Approaches 2026

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: Primary Care Physicians, Medical Geneticists, Surgical Oncologists, Gynecologic Oncologists, Dermatologists, Hematologists, Medical Oncologists

+ Sample video: contact me for sample video

+ Information:

Elevate your approach to cancer prevention with this dynamic course offering practical guidance on current screening practices, management of high-risk populations, and the integration of emerging early detection technologies into clinical care. We will provide a comprehensive review of current cancer screening guidelines, provide guidance regarding high-risk populations and their management, educate regarding emerging technologies for early cancer detection, and provide referral pathways for complex patients.

Learning Objectives

• Identify and implement current cancer screening guidelines, with a focus on early detection and intervention for high-risk populations, and provide recommendations for managing these patients.

• Identify and establish appropriate referral pathways for patients with pre-malignant conditions requiring specialized care.

• Evaluate emerging technologies in cancer detection and assess their application for early detection of cancer.

Target Audience

Specialty Physicians, Physician Assistants, Nurse Practitioners, Primary Care Physicians, and Genetic Counselors.

Best for Primary Care Physicians, Medical Geneticists, Surgical Oncologists, Gynecologic Oncologists, Dermatologists, Hematologists, Medical Oncologists, Urologists, Gastroenterologists, Pulmonologists, and Diagnostic Radiologists.

Topics

• Welcome and Kick Off

• Advancing Early Detection and Interception from the Perspective of the Primary Care Physician

• Q&A: Perspective of the Primary Care Physician

• Genetics 101: Genetic Testing for Inherited Cancer Predisposition in Your Practice

• Management of Hereditary Cancer Predisposition in Your Practice

• The PREMM plus Model / An Easy Way to Identify At Risk Individuals in Your Practice

• Management of DCIS (Ductal Carcinoma in Situ) and Other Breast Cancer Precursors

• Screening and Early Detection of Gynecologic Malignancies

• Q&A: Genetics, Breast Precursors, and Gynecologic Malignancies

• Screening and Early Detection of Dermatologic Malignancies

• Unexplained Cytopenia – When to Consider Clonal Hematopoiesis and Myelodysplastic Syndrome (MDS)

• Intercepting Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma

• Q&A: Cytopenia, MDS, MGUS, and Dermatologic Malignancies

• Screening and Early Detection of Prostate Cancer

• Approach to the Management of Gastrointestinal Precursor Cancer Lesions

• Screening and Early Detection of Lung Cancer

• Screening and Early Detection of Genitourinary Cancers

• Q&A: GI Precursor Lesions, Lung Cancer, and Genitourinary Cancers

• Implementation of Cervical Cancer Screening and Early Detection in the Community

• Multi-Cancer Early Detection Tests – Ready for Prime Time?

• Whole Body Imaging for Screening and Early Detection of Cancer – Promises and Pitfalls

• Panel Discussion: Looking to the Future of Early Detection and Interception

• Networking Reception